Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chronic pain, epilepsy, and inflammatory conditions.

Synthetic cannabinoids, a class of new psychoactive substances, have emerged as a significant public health and social stability threat due to their structural diversity, rapid iteration, and stronger ...

For example, multiple hemp shop operators in Austin have told the Chronic that customers who buy CBD oil for therapeutic use ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

Objective: To test the effectiveness and long term safety of cannabinoids in multiple sclerosis (MS), in a follow up to the main Cannabinoids in Multiple Sclerosis (CAMS) study. Methods: In total, 630 ...

Exhale Wellness launches its new line of Delta 9 Gummies - Bottle Caps. Learn about the product - ingredients, flavors, lab ...

Medical cannabis sativa has evolved from traditional remedy to pharma product, reflecting major shifts in science and society ...

THCA Vapes Dominate Premium Cannabis Market as Area 52 Named Best THCA Vape of 2025Las Vegas, NV, July 06, 2025 (GLOBE NEWSWIRE) -- In a ground ...

While competitors push high-THC options, Area 52’s Delta 8 Gummies lead with a balanced, clear-headed experience-now joined ...

Teen vaping habits are shifting toward stronger and more mysterious substances. Synthetic cannabinoids are rising fast — and ...